Melanoma arising from pre-existing naevus in carriers of a germline CDKN2A pathogenic variant.

Autor: Rauwerdink DJW; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Hoogland Y; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Schrader AMR; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Potjer TP; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van der Hage JA; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Dermatology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2024 Oct 29. Date of Electronic Publication: 2024 Oct 29.

Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma.

Autor: van Duin IAJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CG Utrecht, the Netherlands., Schuiveling M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CG Utrecht, the Netherlands. Electronic address: m.schuiveling@umcutrecht.nl., Ter Maat LS; Image Sciences Institute, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CG Utrecht, the Netherlands., van Amsterdam WAC; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CG Utrecht, the Netherlands., van den Berkmortel F; Department of Medical Oncology, Zuyderland Medical Center Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162 BG, the Netherlands., Boers-Sonderen M; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen 6525 GA, the Netherlands., de Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, Zwolle 8025 AB, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9713 GZ, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, the Netherlands., Labots M; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, Amsterdam 1081 Hz, the Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512 KZ, the Netherlands., Schrader AMR; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, the Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, De Run 4600, Eindhoven 5504 DB, the Netherlands., Westgeest H; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818 CK, the Netherlands., Veta M; Medical Image Analysis, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands., Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CG Utrecht, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CG Utrecht, the Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CG Utrecht, the Netherlands.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 208, pp. 114190. Date of Electronic Publication: 2024 Jun 30.

Cutaneous T-cell lymphoma care across Europe: insights from the HORIZON programme.

Autor: Roccuzzo G; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy., Calvão J; Dermatology Department, Coimbra University Hospital Center, Coimbra, Portugal., Dobos G; Clinic for Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Joint Faculty of Medicine of Freie Universität Berlin and Humboldt-Universität Berlin, Berlin, Germany., Morsia E; Hematology Department, University of Ancona, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona, Italy., Mozas P; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain., Peterknecht E; Department of Dermatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Schrader AMR; Department of Pathology and., Zottarelli F; Dermatology Unit, AOU Maggiore della Carità, Novara, Italy., Bagot M; Department of Dermatology, Hôpital Saint Louis, Université Paris Cité, INSERM U976, Paris, France., Stadler R; University Department of Dermatology, Venereology, Allergology and Phlebology, Skin Cancer Center, Johannes Wesling Medical Centre Minden, Ruhr University Bochum, Bochum, Germany., Vermeer M; Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands., Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy., Scarisbrick J; Department of Dermatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2024 Jul 16; Vol. 191 (2), pp. 284-285.

PD-1 Overexpression in Sézary Syndrome Is Epigenetically Regulated.

Autor: Najidh S; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: s.najidh@lumc.nl., Zoutman WH; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Schrader AMR; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Willemze R; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Tensen CP; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Vermeer MH; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2023 Dec; Vol. 143 (12), pp. 2538-2541.e7. Date of Electronic Publication: 2023 Jun 02.

Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlands.

Autor: Vermariën-Wang J; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Doeleman T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: t.doeleman@lumc.nl., van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Mooyaart AL; Department of Pathology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Blokx WAM; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Schrader AMR; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Mar; Vol. 88 (3), pp. 602-608. Date of Electronic Publication: 2022 Nov 18.